GlobalData on MSN

Genmab reports top line results in Phase III DLBCL trial

Genmab plans to present full results at an upcoming medical meeting.
Clinical Trials Arena on MSN

Roche reports positive top line phase II data for CT-388 in obesity

Participants receiving up to 24mg of CT-388 had a placebo-adjusted weight loss of 22.5% at 48 weeks.
CURE

Onvansertib Combo Improves Outcomes in First-Line RAS-Mutated mCRC

Onvansertib combined with FOLFIRI and Avastin shows dose-dependent improvements in tumor response and disease control for RAS ...
The Manila Times

Cardiff Oncology Announces Positive Update from its Randomized Phase 2 Trial of Onvansertib in First-line RAS-mutated mCRC

Onvansertib added to FOLFIRI/bev first-line standard of care regimen showed dose-dependent improvement in overall response rates and durability trends as measured by progression-free survival in patie ...
Seeking Alpha

Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain

In Both Acute Pain Models, MR-107A-02 Demonstrated Statistically Significant and Clinically Meaningful Improvement in Pain Compared to Placebo, Significant Reduction in Opioid Usage and Superior Pain ...
Nature

Phase Shifters and Transmission Line Technologies

Phase shifters and transmission line technologies are integral components in modern RF and microwave engineering, enabling precise control of signal phase for applications ranging from beamforming in ...
WPXI

PRT awards $99.8M for second phase of University Line

PITTSBURGH — The second phase of the ongoing University Line project is moving forward. Pittsburgh Regional Transit announced on Friday that a $99.8 million construction contract had been awarded to ...